Market Insights Snapshot
In the realm of Capsules, Level has consistently held a strong position in both California and Nevada. In California, it held the top spot for July and August 2023, before slipping slightly to second place in September and October. Despite this slight drop in ranking, Level remains a top player in the market. Nevada shows a similar trend, with Level maintaining a steady second rank throughout the four months. It's worth noting that while their rankings remain high, there has been a slight decrease in sales over this period, indicating potential market fluctuations or increased competition.
Turning to Vapor Pens, Level's performance in the California market shows room for improvement. In July 2023, it ranked 91st, and although it was not in the top 20 brands for August, it reappeared in the rankings in September and October at 100th and 90th respectively. This indicates a struggle to gain a strong foothold in the Vapor Pens category. However, the upward movement from 100th to 90th place from September to October suggests that Level may be making strides in this category. It will be interesting to see if this upward trend continues in the coming months.
In the California market for cannabis capsules, Level has consistently held a top position, though it has seen a slight decrease in rank from 1st place in July and August 2023 to 2nd place in September and October 2023. This shift corresponds with a similar movement from Breez, which moved up from 2nd to 1st place in the same period. Despite this, Level's sales have remained significantly higher than its closest competitors, ABX / AbsoluteXtracts and Kikoko, which have consistently ranked 3rd and 4th respectively. However, it's worth noting that Kikoko has seen a slight increase in rank from 4th to 3rd place from September to October 2023. The data suggests a highly competitive market with some fluctuation in brand rankings, but Level's strong sales performance indicates a solid market presence.
In October 2023, Level's top-performing product was the 'Protab+ - Lights Out Tablets 10-Pack', which maintained its leading position from the previous months, with sales reaching 5857 units. The second-best seller was the 'Protab - Indica Tablets 10-Pack', climbing one rank from the previous month, with sales figures at 5672 units. Following closely was the 'Protab - Sativa Tablets 10-Pack', which dropped one position to third place, with sales of 5196 units. Notably, the 'Hashtab 100 - Indica Tablet' made a significant leap, moving from unranked to fourth place. The 'Hashtab 100 - Sativa Tablet' rounded out the top five, maintaining its position from July, with sales slightly declining.